Locally Advanced Urethral Urothelial Carcinoma
6 clinical trials · Condition
◉ Watch Locally Advanced Urethral Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153) | National Cancer Institute (NCI) | 2022-07-07 |
| Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594) | Alliance for Clinical Trials in Oncology | 2022-05-27 |
| Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299) | M.D. Anderson Cancer Center | 2021-09-23 |
| Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma (NCT04848519) | Emory University | 2021-05-20 |
| Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780) | National Cancer Institute (NCI) | 2018-07-20 |
Track Locally Advanced Urethral Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.